Comparing the Antiseizure and Neuroprotective Efficacy of LY293558, Diazepam, Caramiphen, and LY293558-Caramiphen Combination against Soman in a Rat Model Relevant to the Pediatric Population

Eitemau Tebyg

• Neuroprotective efficacy of caramiphen against soman and mechanisms of its action
  gan: Figueiredo, TH, et al.
  Cyhoeddwyd: (2011)
• LY293558 prevents soman-induced pathophysiological alterations in the basolateral amygdala and the development of anxiety
  gan: Prager, Eric M., et al.
  Cyhoeddwyd: (2014)
• Efficacy of the GluK1/AMPA Receptor Antagonist LY293558 against Seizures and Neuropathology in a Soman-Exposure Model without Pretreatment and its Pharmacokinetics after Intramuscular Administration
  gan: Apland, James P., et al.
  Cyhoeddwyd: (2013)
• The GluK1 (GluR5) Kainate/α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor Antagonist LY293558 Reduces Soman-Induced Seizures and Neuropathology
  gan: Figueiredo, Taiza H., et al.
  Cyhoeddwyd: (2011)
• Pathophysiological Mechanisms Underlying Increased Anxiety after Soman Exposure: Reduced GABAergic Inhibition in the Basolateral Amygdala
  gan: Prager, Eric M., et al.
  Cyhoeddwyd: (2014)